Remove Healthcare Remove Insurance Remove Pharmaceutical manufacturing
article thumbnail

PhRMA lies to protect pharma profits

World of DTC Marketing

Among the 25 worldwide companies that spend the most on research and development—all more than $5 billion a year—seven are pharmaceutical manufacturers, but eight are automobile or automobile parts companies with profit margins under 10 percent. It also raises healthcare costs for public and private insurers alike.

Pharma 255
article thumbnail

Drug pricing increases are disgraceful

World of DTC Marketing

SUMMARY: (JAMA) The median drug wholesale list price (as defined by Average Wholesale Price) increased by 129% from 2010-2016, while median patient out-of-pocket costs increased by 53% and median insurance payments after rebates and discounts increased by 64%. Say goodbye to all the supposed goodwill.

Insurance 181
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Global Health Equity: Moving From Wish List to To-Do List

Eversana Intouch

We must ensure our messaging is tailored to apply and resonate across cultures, languages, regulations and healthcare systems. Correspondingly, pharmaceutical manufacturers spend exponentially more on marketing healthcare, including more than $6 billion annually on direct-to-consumer advertising.

article thumbnail

Top-10 ways for Pharma to leverage AI according to…AI

Impetus Digital

Manufacturing Optimization While the manufacturing industry lags behind others in terms of AI uptake, there is no shortage of potential ways to leverage this technology.

Pharma 92
article thumbnail

10 New Solutions, Strategies, and Devices to Boost Adherence

PM360

One reason for this growth is an increasing demand for personalized healthcare technologies as patients look for advances in how healthcare is delivered following the pandemic. NovaXS is on a mission to simplify the medication self-administration process and improve remote healthcare adherence. billion in 2030 at a CAGR of 9.2%.

article thumbnail

Precision Medicine Needs an Overhaul

PM360

Unlike the “un”targeted approaches that are often associated on the trial-and-error method, an expanded definition of precision medicine, with a smarter and more integrated tool set, will enable healthcare professionals (HCPs) to try the optimal therapeutic approach… the first time. That said, it’s not all sunshine and roses everywhere.

article thumbnail

A Powerful Point-of-Sale Partnership that Delivers on the Promise of Affordable Insulin

PM360

In March of this year the three largest insulin manufacturers announced a dramatic reduction in the price of many commonly prescribed insulins and a monthly out-of-pocket (OOP) cap of $35 that went into effect in May. for only $35. retail pharmacies to access a 30-day supply of Lantus for only $35.

Retail 52